KLAS-TELECOM
18.9.2018 07:02:10 CEST | Business Wire | Press release
Klas Telecom announced today they will supply the TRX Connected Transportation Platform to global engineering house Ikusi for a project to upgrade the passenger information systems onboard Renfe train fleets. Under a Memorandum of Understanding, Klas Telecom’s TRX platform will provide an onboard Wi-Fi infrastructure that improves connectivity to and within the train so that passengers have a better user experience accessing the mobile information and services they need. Klas Telecom and Ikusi have enjoyed a longstanding relationship in which they have worked together to design and develop bespoke solutions to deliver the exacting requirements stipulated by Ikusi’s railway customers.
Ikusi selected Klas Telecom’s TRX R6 as the key component of the onboard passenger Wi-Fi system. The TRX R6 will deliver reliable, high-bandwidth and low-latency connectivity to the train. Another key component of the passenger Wi-Fi system is the software-defined wide area network (SDWAN) feature of the TRX operating system, KlasOS. The KlasOS SDWAN aggregates WAN links and manages multiple wireless bearers in order to provide the train both higher throughput and availability of the offboard WAN link. Klas Telecom’s advanced SDWAN technology leverages any available Internet connection, whether in-station Wi-Fi or 3G/4G LTE connections. The KlasOS SDWAN feature seamlessly routes traffic over uncongested links to ensure that passengers stay connected at all times whether checking e-mails, updating social media, remote working over VPN or making a video call.
“Our partnership with Klas Telecom has gone from strength to strength in recent years,” Ikusi Director of Railway Solutions José Morales said. “We can count on their competence to develop the most appropriate solution to meet the project requirements every time. This Memorandum of Understanding ensures that Ikusi continues to work closer than ever to Klas Telecom, ultimately resulting in greater passenger satisfaction for our customers.”
Brendan Fleming, Klas Telecom Director of Business Development for Transportation, added, “Working with a partner like Ikusi allows us to demonstrate what we do best: developing and supplying the latest cutting-edge technology as part of an onboard Wi-Fi solution, allowing the end customer to provide an optimum passenger experience.”
You can view Klas Telecom’s TRX platform this week at InnoTrans 2018 in Hall 7.1B at Messe Berlin.
More About Klas Telecom
With a background in satellite communications, Klas Telecom is an engineering and design company with over 25 years of experience developing innovative communications solutions for the network edge. Klas Telecom delivers connectivity to communications black spots and austere environments where low size, weight, power and ruggedization are required. The company specializes in integrating enterprise networking capabilities from global IT leaders with in-house hardware and software platforms designed and proven against the most stringent environmental requirements. With over 80% of the company dedicated to technology development, Klas Telecom is able to stay on the forefront of the deployable communications technology. Klas Telecom operates in the public safety, transportation and U.S. and international defense markets. The company employs staff across four offices located in Washington, DC; Herndon, VA; Tampa, FL; and Dublin, Ireland. www.klastelecom.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180917005821/en/
Contact:
Klas Telecom Carrie Sarver Hall | VP of Marketing and Communications 202-288-6342 carrie.hall@klastelecom.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
Seoul Viosys Eyes the $60 Billion AI Data Center Optical Communication Market with Opto Semiconductors27.4.2026 15:00:00 CEST | Press release
Joint Development Talks with Global Optical Communications companiesExpanding Partnerships to Provide Total Transceiver Solution1,800 Patents Secured for High-Performance Optical Communications Seoul Viosys (KOSDAQ: 092190), a company specializing in opto-semiconductor devices, is accelerating its entry into the next-generation photonics market supported by its proprietary “No-wire” and “No-package” fundamental patents—essential technologies for micrometer (μm)-scale miniaturization of opto-semiconductors—as well as its competitiveness in VCSEL technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426926495/en/ Seoul Viosys Optoelectronic Semiconductor Structure Subject to a Permanent U.S. Injunction in February 2026, Covering Similar Products and Employees (Image: Seoul Viosys) As the rapid expansion of AI drives a paradigm shift in data centers from copper-based to optical-based architectures, the company is streng
vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 14:51:00 CEST | Press release
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
